EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sex‐based differences in cardiac resynchronization therapy upgrade and outcome for patients with pacemaker and new‐onset heart failure

Cecilia Rorsman, Maiwand Farouq, Sofia Marinko, David Mörtsell iD, Uzma Chaudhry, Lingwei Wang, Rasmus Borgquist iD

Pacing and Clinical Electrophysiology · 2023

DOI: 10.1111/pace.14796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2023. Verfasst von Cecilia Rorsman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology, Department of Clinical, Sciences, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Heart Failure, Cardiac Resynchronization Therapy, Pacemaker, Artificial. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with chronic right ventricular (RV) pacing are at an increased risk of heart failure. Previous studies have indicated that cardiac resynchronization therapy (CRT) is underused in this setting, and that there may be sex‐based differences in both CRT use and clinical outcome.

Objective

To evaluate sex‐based differences in CRT use and clinical outcome for patients with new‐onset heart failure post RV pacing.

Methods

Data from the Swedish pacemaker registry was matched with data from the national death and disease registries. Patients with de novo pacemaker implant due to AV block during the period 2005–2020 were included. New‐onset heart‐failure within two years post‐implant was evaluated, primary outcome was all‐cause mortality.

Results

In all, 30183 patients (37% female) were included. Women were on average 3 years older, but had less comorbidities than men. Median follow‐up time was 4.5 [2.0–8.0] years. Women had better age‐ and comorbidity‐adjusted survival (HR 0.78 [0.73–0.84], p < .001). For the 3560 patients (12.4% men and 10.7% women, p < .001) who were diagnosed with new‐onset heart failure, 5‐year mortality was similar for men and women (50% vs. 48%, p = .29). However, women were less likely to receive CRT‐upgrade (3.8% vs. 9.1%, p < .001), and those who did were almost ten years younger than the men.

Conclusion

Women with pacemaker due to AV block are older but have less comorbidities than men. They are less likely to develop new‐onset heart failure, but also less likely to receive a CRT upgrade if they do develop heart failure. Increased awareness of the positive effects of CRT upgrade and potential sex‐ and age‐based discrimination is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCardiac Resynchronization TherapyPacemaker, ArtificialHumansMaleFemaleAgedRegistriesSex FactorsSwedenTreatment OutcomeAged, 80 and over

Stichwörter der Autor:innen

cardiac resynchronization therapyheart failurepacemakerprognosis

Autor:innen und Institutionen

  • Cardiology, Department of Clinical, Sciences, Lund University, Lund, Sweden.
  • Internal Medicine Department, Varberg Hospital, Varberg, Sweden.
  • Arrhythmia Section, Skane University Hospital, Lund, Sweden.

ORCID-Profile: David Mörtsell, Rasmus Borgquist

Zitieren

APA

Rorsman, C., Farouq, M., Marinko, S., Mörtsell, D., Chaudhry, U., Wang, L., & Borgquist, R. (2023). Sex‐based differences in cardiac resynchronization therapy upgrade and outcome for patients with pacemaker and new‐onset heart failure. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14796

Vancouver

Rorsman C, Farouq M, Marinko S, Mörtsell D, Chaudhry U, Wang L, et al. Sex‐based differences in cardiac resynchronization therapy upgrade and outcome for patients with pacemaker and new‐onset heart failure. Pacing and Clinical Electrophysiology. 2023. doi:10.1111/pace.14796

BibTeX
@article{Rorsman2023,
  author = {Rorsman, Cecilia and Farouq, Maiwand and Marinko, Sofia and Mörtsell, David and Chaudhry, Uzma and Wang, Lingwei and Borgquist, Rasmus},
  title = {Sex‐based differences in cardiac resynchronization therapy upgrade and outcome for patients with pacemaker and new‐onset heart failure},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2023},
  doi = {10.1111/pace.14796}
}
Kostenlos starten →